Store

Home | Store | In Vitro Diagnostics (IVD) in the Middle East and Africa

In Vitro Diagnostics (IVD) in the Middle East and Africa

Publication Date: May 27, 2022

SKU: 22-034

Tags: AMEA, Coagulation, Genetic Diseases, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, Middle East, Molecular Diagnostics, Oncology and Cancer, Point-of-Care (POC) Testing

Pages: 100

SKU: 22-034

Stay informed and gain a competitive edge with this comprehensive and insightful report on the IVD market in the Middle East and Africa from Kalorama Information. Rising national incomes and improved living standards in these regions have led to a higher incidence of heart disease, including high blood pressure, cholesterol, and blood sugar levels, increasing hospital admissions and driving the demand for diagnostic and medical devices.

 

Report Highlights:

  • Countries Covered:
    • Middle East: Egypt, Iran, Iraq, Israel, Jordan, Saudi Arabia, Turkey, United Arab Emirates (UAE), and other Mideast countries (Bahrain, Cyprus, Gaza Strip, Kuwait, Lebanon, Oman, Qatar, Syria, West Bank, Yemen).
    • Africa: South Africa, Algeria, Congo, Sudan, Libya, Chad, Niger, Angola, Mali, Ethiopia, and more.

 

Segments Covered:

  • Clinical Chemistry
  • Immunoassay
  • Microbiology
  • Point of Care (POC)
  • Histology (traditional stains)
  • Other Segments: Includes nucleic acid assays, blood bank ABO, sequencing, prenatal tests, and other areas not covered specifically in the above segments.

 

Market Scope:

  • The report provides the IVD market value in U.S. dollars for the years 2021-2026.
  • Includes detailed analysis of market growth derived from increased test usage in emerging countries.
  • Highlights significant growth in Turkey and Saudi Arabia, driven by investments in healthcare infrastructure and insurance coverage for an increasingly affluent middle class.

 

Key Insights:

  • Anticipated new availability of tests and test systems designed for use in resource-poor settings.
  • Increased consolidation of healthcare services worldwide, leading to pricing pressure on all medical devices, including IVDs.
  • Expansion opportunities due to increased healthcare insurance availability in emerging countries, enabling more people to access healthcare services.

 

Table: Iraq In Vitro Diagnostic Sales, by Market Segment, 2021-2026 (in millions $)
Segment Sales $
2021
% Mkt Sales $
2026
% Mkt CAGR
Clinical Chemistry $XX Million XX% $XX Million XX% XX%
Immunoassay $XX Million XX% $XX Million XX% XX%
Microbiology $XX Million XX% $XX Million XX% XX%
POC $XX Million XX% $XX Million XX% XX%
Histology $XX Million XX% $XX Million XX% XX%
Other $XX Million XX% $XX Million XX% XX%
Total $XX Million XX% $XX Million XX% XX%
Source: Kalorama Information

For further details and to purchase directly, please contact us.

 

Table of Contents

Chapter 1: Executive Summary

Overview

Scope and Methodology

Size and Growth of the Market

  • Figure 1-1: IVD in the Middle East, Africa, 2021-2026 CAGR 2.2% ($ millions)

 

Chapter 2: Middle East and Africa: Regional Overview

Overview

Regional Market Overview

  • Table 2-1: Mideast/Africa In Vitro Diagnostic Sales by Country, 2021-2026 ($ millions) (Egypt, Iran, Iraq, Israel, Jordan, Saudi Arabia, Turkey, United Arab Emirates, Other Mideast, South Africa, Other Africa, Total)
  • Figure 2-1: Mideast/Africa In Vitro Diagnostic Sales by Country, 2021-2026 – Eight Countries Generate nearly 75% Market Value (Egypt, Iran, Iraq, Israel, Jordan, Saudi Arabia, Turkey, United Arab Emirates, Other Mideast, South Africa, Other Africa)

Population

  • Table 2-2: Elderly Dependency Ratio in Middle East and Other Select Countries, 2010 and 2050
  • Table 2-3: World Population: Major Countries in the Mideast and Africa Region (Egypt, Iraq, Iran, Israel, Jordan, Saudi Arabia, South Africa, Turkey, United Arab Emirates), 2010-2030 (million persons)
  • Figure 2-2: Middle East and Africa Region, Population Density by Country, 2022 Est.

Major Diseases Affecting the Middle Eastern / African Population

Cardiovascular Diseases

Cancer

  • Table: 2-4: The Most Frequent Cancers by Country of Middle East and Africa (%) As Reported by National Cancer Registry Programs, 2020

Diabetes

  • Table 2-5: People Living with Diabetes in Middle East/Africa Region and Projections 2045 (millions of people)

Middle Eastern Respiratory Syndrome (MERS)

MERS Situation Update, February 2022

  • Table 2-6: Epidemiological Characteristics of MERS Cases Reported Globally, (Dec 2017 – May 2018 through Sept 2021 – Feb 2022)

Market Response to MERS

SARS-CoV-2 (COVID-19)

COVID-19 Situation in MEA

Market Response to COVID-19

  • Table 2-7: Selected MEA COVID-19 Statistics – Total Cases, Total Deaths, New Cases Last 7 Days, May 20, 2022
  • Figure 2-3: Selected MEA COVID-19 Statistics – Total Cases, Total Deaths, New Cases Last 7 Days , May 20, 2022

 

Chapter 3: Egypt IVD Market

Overview

Market Summary

  • Table 3-1: Egypt In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total)  ($ millions)
  • Figure 3-1: Egypt In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total)  ($ millions)
  • Table 3-2: Egypt – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
  • Figure 3-2: POC Market Distribution (POC Glucose, POC Other) for Egypt, 2021 and 2026

Market Strengths and Weaknesses (Drivers and Inhibitors)

  • Figure 3-3: Egypt IVD Market: Strengths and Weaknesses

COVID-19 Pandemic Situation

  • Table 3-3: COVID-19 Pandemic Situation: Egypt, updated May 20, 2022
  • Figure 3-4: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022

Market Participant Activity

  • Figure 3-5: Selected IVD-Related Participant Activity: Egypt

 

Chapter 4: Iran IVD Market

Overview

  • Figure 4-1: Iran’s Crude Oil Production, 1975 – 2020 (millions of barrels per day)

Market Summary

  • Table 4-1: Iran In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total)  ($ millions)
  • Figure 4-2: Iran In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total)  ($ millions)
  • Table 4-2: Iran – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
  • Figure 4-3: POC Market Distribution (POC Glucose, POC Other) for Iran, 2021 and 2026

Market Strengths and Weaknesses (Drivers and Inhibitors)

  • Figure 4-4: Iran IVD Market: Strengths and Weaknesses

COVID-19 Pandemic Situation

  • Table 4-3: COVID-19 Pandemic Situation: Iran, updated May 20, 2022
  • Figure 4-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022

 

Chapter 5: Iraq IVD Market

Overview

  • Figure 5-1: Iraq’s Production and Consumption of Petroleum and Other Liquids, 1990 – 2020 (millions of barrels per day)

Market Summary

  • Table 5-1: Iraq In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
  • Figure 5-2: Iraq In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total)  ($ millions)
  • Table 5-2: Iraq – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
  • Figure 5-3: POC Market Distribution (POC Glucose, POC Other) Percent for 2021 and 2026

Market Strengths and Weaknesses (Drivers and Inhibitors)

  • Figure 5-4: Iraq IVD Market: Strengths and Weaknesses

COVID-19 Pandemic Situation

  • Table 5-3: COVID-19 Pandemic Situation: Iraq, updated May 20, 2022
  • Figure 5-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022

Market Participant Activity

  • Figure 5-6: Selected IVD-Related Participant Activity: Iraq

 

Chapter 6: Israel IVD Market

Overview

Market Summary

  • Table 6-1: Israel In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
  • Figure 6-1: Israel In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total)  ($ millions)
  • Table 6-2: Israel – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
  • Figure 6-2: POC Market Distribution (POC Glucose, POC Other) for Israel, 2021 and 2026

Market Strengths and Weaknesses (Drivers and Inhibitors)

  • Figure 6-3: Israel IVD Market: Strengths and Weaknesses

COVID-19 Pandemic Situation

  • Table 6-3: COVID-19 Pandemic Situation: Israel, updated May 20, 2022
  • Figure 6-4: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022

Market Participant Activity

  • Figure 6-5: Selected IVD-Related Participant Activity: Israel

 

Chapter 7: Jordan IVD Market

Overview

Market Summary

  • Table 7-1: Jordan In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
  • Figure 7-1: Jordan In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total)  ($ millions)
  • Table 7-2: Jordan – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
  • Figure 7-2: POC Market Distribution (POC Glucose, POC Other) for Jordan, 2021 and 2026

Market Strengths and Weaknesses (Drivers and Inhibitors)

  • Figure 7-3: Jordan IVD Market: Strengths and Weaknesses

COVID-19 Pandemic Situation

  • Table 7-3: COVID-19 Pandemic Situation: Jordan, updated May 20, 2022
  • Figure 7-4: COVID-19 Pandemic Confirmed Case Pattern, through May 15, 2022

 

Chapter 8: Saudi Arabia IVD Market

Overview

  • Figure 8-1: Saudi Arabia Crude Oil Production, Annual Average Per Day (millions of barrels), 1995-2020

Market Summary

  • Table 8-1: Saudi Arabia In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
  • Figure 8-2: Saudi Arabia In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total)  ($ millions)
  • Table 8-2: Saudi Arabia – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
  • Figure 8-3: POC Market Distribution (POC Glucose, POC Other) for Saudi Arabia, 2021 and 2026

Market Strengths and Weaknesses (Drivers and Inhibitors)

  • Figure 8-4: Saudi Arabia IVD Market: Strengths and Weaknesses

COVID-19 Pandemic Situation

  • Table 8-3: COVID-19 Pandemic Situation: Saudi Arabia, updated May 20, 2022
  • Figure 8-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022

Market Participant Activity

  • Figure 8-6: Selected IVD-Related Participant Activity: Saudi Arabia

 

Chapter 9: South Africa IVD Market

Overview

Market Summary

  • Table 9-1: South Africa In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
  • Figure 9-1: South Africa In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total)  ($ millions)
  • Table 9-2: South Africa – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
  • Figure 9-2: POC Market Distribution (POC Glucose, POC Other) for South Africa, 2021 and 2026

Market Strengths and Weaknesses (Drivers and Inhibitors)

  • Figure 9-3: South Africa IVD Market: Strengths and Weaknesses

Ebola Outbreaks

  • Figure 9-4: DRC Ebola Virus Disease Outbreak: Equateur Province, 2022 (Provinces and Health Zones)
  • Table 9-3: Ebola Virus Outbreaks by Species and Size, 1976 – 2021

COVID-19 Pandemic Situation

  • Table 9-4: COVID-19 Pandemic Situation: South Africa, updated May 20, 2022
  • Figure 9-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022

Market Participant Activity

  • Figure 9-6: Selected IVD-Related Participant Activity: South Africa

 

Chapter 10: Turkey IVD Market

Overview

Market Summary

  • Table 10-1: Turkey In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
  • Figure 10-1: Turkey In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total)  ($ millions)
  • Table 10-2: Turkey – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
  • Figure 10-2: POC Market Distribution (POC Glucose, POC Other) for Turkey, 2021 and 2026

Market Strengths and Weaknesses (Drivers and Inhibitors)

  • Figure 10-3: Turkey IVD Market: Strengths and Weaknesses

COVID-19 Pandemic Situation

  • Table 10-3: COVID-19 Pandemic Situation: Turkey, updated May 20, 2022
  • Figure10-4: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022

Market Participant Activity

  • Figure 10-5: Selected IVD-Related Participant Activity: Turkey

 

Chapter 11: United Arab Emirates (UAE) IVD Market

Overview

  • Figure 11-1: UAE’s Production and Consumption of Petroleum and Other Liquids, 2008-2018 (millions of barrels per day)

Market Summary

  • Table 11-1: United Arab Emirates In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
  • Figure 11-2: United Arab Emirates In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total)  ($ millions)
  • Table 11-2: United Arab Emirates – POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
  • Figure 11-:3 POC Market Distribution (POC Glucose, POC Other) for United Arab Emirates, 2021 and 2026

Market Strengths and Weaknesses (Drivers and Inhibitors)

  • Figure 11-4: United Arab Emirates IVD Market: Strengths and Weaknesses

COVID-19 Pandemic Situation

  • Table 11-3: COVID-19 Pandemic Situation: United Arab Emirates, updated May 20, 2022
  • Figure 11-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022

Market Participant Activity

  • Figure 11-6: Selected IVD-Related Participant Activity: United Arab Emirates

 

Chapter 12: Total Mideast & Africa IVD Market

Overview

Summary

  • Table 12-1: Mideast/Africa In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)

Clinical Chemistry Market

Immunoassay Market

Microbiology Market

Point-of-Care Market

Histology Market

Our Knowledge Center provides access to

all market reports